GALLI, Diego
 Distribuzione geografica
Continente #
NA - Nord America 354
EU - Europa 143
AS - Asia 63
AF - Africa 3
Totale 563
Nazione #
US - Stati Uniti d'America 354
IT - Italia 59
CN - Cina 37
UA - Ucraina 23
FI - Finlandia 16
DE - Germania 15
SG - Singapore 13
GB - Regno Unito 10
FR - Francia 6
HK - Hong Kong 6
BE - Belgio 4
IE - Irlanda 4
CZ - Repubblica Ceca 3
IN - India 3
TR - Turchia 3
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
PL - Polonia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 563
Città #
Fairfield 57
Brescia 45
Houston 43
Woodbridge 37
Seattle 31
Ashburn 22
Cambridge 22
Jacksonville 20
Wilmington 19
Chandler 18
Helsinki 13
Singapore 9
New York 8
Princeton 8
Beijing 7
Dearborn 6
Hong Kong 6
Nanjing 6
Ann Arbor 5
Brussels 4
Dublin 4
Munich 4
San Diego 4
Shenyang 4
Istanbul 3
Olomouc 3
San Mateo 3
Zhengzhou 3
Acton 2
Changsha 2
Highland 2
London 2
Los Angeles 2
Milan 2
Pisogne 2
Sant'anastasia 2
Shanghai 2
Taizhou 2
Athens 1
Avigliano 1
Cairo 1
Centurion 1
Des Moines 1
Espoo 1
Hangzhou 1
Hebei 1
Jakarta 1
Jinan 1
Kilburn 1
Kunming 1
Lutzingen 1
Norwalk 1
Phoenix 1
Pune 1
Southwark 1
Taiyuan 1
Tunis 1
Wandsworth 1
Warsaw 1
Totale 455
Nome #
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 189
Palbociclib inhibits proliferation of human adrenocortical tumor cells 136
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 129
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 128
Totale 582
Categoria #
all - tutte 2.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020114 0 0 0 0 10 19 16 15 18 26 3 7
2020/202185 2 7 7 7 9 6 2 6 13 10 13 3
2021/202259 3 5 0 1 0 1 2 3 1 4 4 35
2022/202359 8 7 2 5 6 6 0 8 10 0 3 4
2023/202463 4 2 9 5 2 14 5 4 6 3 2 7
2024/202527 1 2 0 19 5 0 0 0 0 0 0 0
Totale 582